Watch Ticker

Polyrizon Ltd. Ordinary Shares

Go to Polyrizon Ltd. Ordinary Shares Website

$1.16

0.00 (0.00%)

Live

Previous Close

$1.16

Day Range

$0 - $0

Previous Day Range

$1.135 - $1.2139

Market Cap

$6.3 million USD

Day Vol.

Previous Day Vol.

662100

Currency

USD

Primary Exchange

None

Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also con...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Rishabh Mishra - US Stocks Likely To Open Lower After S&P 500's 9-Day Streak: 'Any De-Escalation In Trade Tensions Should Be Positive,' Says Expert

U.S. stock futures fell on Monday after a nine-day winning streak on the S&P 500 index. Investors will keep an eye on the Federal Reserve's decision on interest rates this week. Analysts say any de-escalation in trade tensions should be positive for the economy and financial markets.

Related tickers: BON, CMI, F, FpB, FpC, FpD, FFAI, FFAIW, HSIC, PLRZ, QQQ, RNAZ, SPY, TSN.

Read Full Article

Polyrizon Ltd. - Polyrizon Initiates Preclinical Studies for Intranasal Naloxone Targeting Opioid Overdose Based on Its Innovative T&T Platform

Polyrizon, a biotech company, has initiated preclinical studies for intranasal Naloxone, a treatment for opioid overdose, using its Trap and Target (T&T) platform. The studies aim to assess key parameters like drug loading, release kinetics, and nasal deposition, paving the way for further safety and efficacy testing.

Related tickers: PLRZ.

Read Full Article

Trending Tickers

Please sign in to view